Exciting new material for long-acting drug delivery

Description

HIV/AIDS remains a major global health challenge, with an estimated 39 million people living with the disease and 1.5 million new infections each year. Though antiretroviral therapy provides effective treatment and prevention, limitations arise due to inadequate adherence to the required lifelong daily drug regimen. There is thus significant interest in the development of long-acting drug delivery systems that enable consistent and sustained drug release for extended periods. Researchers from Queen’s University Belfast have recently published proof-of-concept of a long-acting drug delivery platform based on a novel peptoid-peptide material. The contribution to this work by the Institut Laue-Langevin (ILL) demonstrates, once again, the facility’s dedication to the provision of neutrons for society.